Topical hemostatic and tissue-sealing agents in gynecologic surgery.
Cullifer RM, Makai G, Pacis M, Huynh T. Topical hemostatic and tissue-sealing agents in gynecologic surgery. Current Opinion In Obstetrics & Gynecology 2020, 32: 285-291. PMID: 32324712, DOI: 10.1097/gco.0000000000000632.Peer-Reviewed Original ResearchConceptsTopical hemostatic agentsGynecologic surgeryPotential complicationsShorter operating room timeHemostatic agent useSmall bowel obstructionBlood-borne pathogensOperating room timeMechanism of actionOvarian cystectomyAbdominal myomectomyBowel obstructionOvarian reserveBlood lossAbscess formationAllergic reactionsAgent useRoom timeSurgery proceduresHemostatic agentsSurgeryEfficacious useSurgical subspecialtiesTopical hemostaticsOperating timePreoperative Gabapentin for Minimally Invasive Hysterectomy: A Randomized Controlled Trial
Huynh TQ, Patel NR, Goldstein ND, Makai GE. Preoperative Gabapentin for Minimally Invasive Hysterectomy: A Randomized Controlled Trial. Journal Of Minimally Invasive Gynecology 2020, 28: 237-244.e2. PMID: 32389735, DOI: 10.1016/j.jmig.2020.04.040.Peer-Reviewed Original ResearchMeSH KeywordsAcetaminophenAdultAgedAnalgesics, OpioidCelecoxibDouble-Blind MethodDrug Administration ScheduleDrug Therapy, CombinationEnhanced Recovery After SurgeryFemaleGabapentinHumansHysterectomyMiddle AgedMinimally Invasive Surgical ProceduresNarcoticsPain MeasurementPain, PostoperativePreoperative PeriodUterine DiseasesConceptsPreoperative gabapentinTotal narcoticsPain scoresInvasive hysterectomyStudy armsAcademic-affiliated community hospitalAdverse effectsOral morphineGabapentin usePreoperative regimenSecondary outcomesControlled TrialsPrimary outcomeBenign indicationsSingle doseSurgical detailsControl armCommunity hospitalGabapentinSurgeryControl groupDemographic characteristicsNarcoticsHysterectomyWomenPrenatal care in a specialized diabetes in pregnancy program improves compliance with postpartum testing in GDM women*
Huynh T, Ghaffari N, Bastek J, Durnwald C. Prenatal care in a specialized diabetes in pregnancy program improves compliance with postpartum testing in GDM women*. The Journal Of Maternal-Fetal & Neonatal Medicine 2016, 30: 1075-1079. PMID: 27296556, DOI: 10.1080/14767058.2016.1201472.Peer-Reviewed Original ResearchConceptsGDM womenPrenatal carePregnancy programPregnancy clinicOral glucose tolerance testRetrospective cohort studyGlucose tolerance testUniversity Health SystemRate of completionTime trend analysisPostpartum testingPostpartum visitClinical characteristicsCohort studyPrimary outcomePotential confoundersPrenatal clinicsTolerance testPostpartum periodDiabetesHealth systemClinicCareWomenSecular trends